Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-016579
Filing Date
2015-03-17
Accepted
2015-03-17 09:46:37
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v403266_10k.htm 10-K 960222
2 EXHIBIT 23.1 v403266_ex23-1.htm EX-23.1 3335
3 EXHIBIT 31.1 v403266_ex31-1.htm EX-31.1 8565
4 EXHIBIT 32.1 v403266_ex32-1.htm EX-32.1 4304
11 GRAPHIC diagram_1.jpg GRAPHIC 111788
12 GRAPHIC diagram_2.jpg GRAPHIC 121722
  Complete submission text file 0001144204-15-016579.txt   11673904

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nwbo-20141231.xml EX-101.INS 1709699
6 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20141231.xsd EX-101.SCH 96348
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20141231_cal.xml EX-101.CAL 50539
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20141231_def.xml EX-101.DEF 462600
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20141231_lab.xml EX-101.LAB 549176
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20141231_pre.xml EX-101.PRE 522023
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 15705055
SIC: 2834 Pharmaceutical Preparations